Russian Journal of BiotherapyRussian Journal of BiotherapyРоссийский биотерапевтический журнал1726-97841726-9792Publishing House ABV Press121310.17650/1726-9784-2020-19-3-12-20REVIEWSОБЗОРЫ ЛИТЕРАТУРЫPHYTOADAPTOGENS IN THE TUMOURS BIOTHERAPY AND GERIATRICS (PART 2)ФИТОАДАПТОГЕНЫ В БИОТЕРАПИИ ОПУХОЛЕЙ И ГЕРИАТРИИ (ЧАСТЬ 2)https://orcid.org/0000-0002-6365-2888BocharovaO. A.БочароваО. А.
Russian Federation

Ольга Алексеевна Бочарова

imufarm@rambler.ruhttps://orcid.org/0000-0003-4893-1472KarpovaR. V.КарповаР. В.
Russian Federation
https://orcid.org/0000-0003-2342-9881BocharovE. V.БочаровЕ. В.
Russian Federation
VershinskayaA. A.ВершинскаяА. А.
Russian Federation
BaryshnikovaM. A.БарышниковаМ. А.
Russian Federation
KazeevI. V.КазеевИ. В.
Russian Federation
https://orcid.org/0000-0002-5071-3581KucheryanuV. G.КучерянуВ. Г.
Russian Federation
https://orcid.org/0000-0002-0132-167XKiselevskiyM. V.КиселевскийМ. В.
Russian Federation
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian FederationФГБУ «Национальный медицинский исcледовательский центр онкологии им. Н.Н. Блохина» Минздрава РоссииInstitute of General Pathology and PathophysiologyФГБНУ «Научно-исследовательский институт общей патологии и патофизиологии»1310202019312201210202012102020https://bioterapevt.abvpress.ru/jour/article/view/1213

Phytoadaptogens (ginseng, eleutherococcus, rhodiola rosea, aralia, etc.) have a wide spectrum of biological activity, supporting the body in a state of nonspecific increased resistance to stress. The second part of the review provides information of the phytoadaptogens normalizing effects on the cardiovascular system. Analyzes current data on the antitumor properties of phytoadaptogens in relation to the effect on the onset and development of tumours, metastasis, recurrence, development of cytostatic disease, confirming the prospect of their using in drugs for prevention and biotherapy of tumour diseases.

Past 1 see: Phytoadaptogens in the tumours biotherapy and geriatrics (Past 1). Russian Journal of Biotherapy 2020;19(2):13–21.

Фитоадаптогены (женьшень, элеутерококк, родиола розовая, аралия и др.) обладают широким спектром биологической активности, поддерживая организм в состоянии неспецифически повышенной сопротивляемости к стрессовым воздействиям. Во 2-й части обзора приводятся сведения о нормализующем влиянии фитоадаптогенов на сердечно-сосудистую систему. Проводится анализ современных данных о противоопухолевых свойствах фитоадаптогенов в отношении влияния на возникновение и развитие опухолей, метастазирование, рецидивирование, развитие цитостатической болезни, подтверждающий перспективу их использования в создании препаратов для профилактики и биотерапии опухолевых заболеваний.

Часть 1 см.: Фитоадаптогены в биотерапии опухолей и гериатрии (Часть 1). Российский биотерапевтический журнал 2020;19(2):13–21. Past 1 see: Phytoadaptogens in the tumours biotherapy and geriatrics (Past 1). Russian Journal of Biotherapy 2020;19(2):13–21.

ADAPTOGENSGINSENGELEUTHEROCOCCUSPREVENTIVE ONCOLOGYGEROPROTECTORSIMMUNOMODULATORSANTITUMOUR THERAPYАДАПТОГЕНЫЖЕНЬШЕНЬЭЛЕУТЕРОКОККПРОФИЛАКТИЧЕСКАЯ ОНКОЛОГИЯГЕРОПРОТЕКТОРЫИММУНОМОДУЛЯТОРЫПРОТИВООПУХОЛЕВАЯ ТЕРАПИЯGan X.T., Karmazyn M. Cardioprotection by ginseng: experimental and clinical evidence and underlying mechanisms. Can J Physiol Pharmacol 2018;96(9):859–68. DOI: 10.1139/cjpp-2018-0192.Bocharova O.A., Baryshnikov A.Yu., Davydov M.I. Phytoadaptogens in oncology and gerontology. Moscow: Medical News Agency, 2008. 224 p. (In Russ.).Бочарова О.А., Барышников А.Ю., Давыдов М.И. Фитоадаптогены в онкологии и геронтологии. М.: МИА, 2008. 224 с.Nakaya Y., Mawatari K., Takahashi A. et al. The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways. J Med Invest 2007;(54):381–4. DOI: 10.2152/jmi.54.381.Nabavi S.F., Sureda A., Habtemariam S., Nabavi S.M. Ginsenoside Rd and ischemic stroke; a short review of literatures. J Gin Res 2015;39(4):299–303. DOI: 10.1016/j.jgr.2015.02.002.Yue P.J., Мак N.K., Cheng J.K. et al. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007;(2):6–10. DOI: 10.1186/1749-8546-2-6.Arushanyan E.B., Beyer E.V. Plant adaptogens. Stavropol’: StSMU, 2009. 232 р. (In Russ.).Арушанян Э.Б., Бейер Э.В. Растительные адаптогены. Ставрополь: СтГМУ, 2009. 232 с.Zhang Y., Zhou L., Zhang X. et al. Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia. Neurol Sci 2012;33(5):1125–31. DOI: 10.1007/s10072-011-0916-6.Chen P.S., Liu J., Meng H.Y. et al. Beneficial effects of Schisandrin B on the cardiac structure and function in a mice model of myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 2017;45(11):963–70. DOI: 10.3760/cma.j.issn.0253-3758.2017.11.013.Xie J.T., Shao Z.H., Vanden Hoek T. Antioxidant effects of ginsenoside Re in cardyomiocytes. Eur J Pharmacol 2006;533(3):201–7. DOI: 10.1016/j.ejphar.2006.01.001.Lishmanov Yu.B., Maslov L.N., Arbuzov A.G. et al. Complex adaptogen drug Tonizid attenuates myocardial contractility dysfunction and prevents the appearance of irreversible cardiomyocyte damage during ischemia and reperfusion in isolated heart. Еksperimentalnaya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology 2008;(3):15–22. (In Russ.).Лишманов Ю.Б., Маслов Л.Н., Арбузов А.Г. и др. Кардиопротекторные, инотропные и антиаритмические свойства комплексного адаптогенного препарата Тонизид. Экспериментальная и клиническая фармакология 2008;(3):15–22. DOI: 10.30906/0869-2092-2008-71-3-15-22.Zhou P., Xie W., He S. et al. Ginsenoside Rb1 as an Anti-diabetic agent and its underlying mechanism analysis. Cells 2019;8(3):1110–5. DOI: 10.3390/cells8030204.Goldberg E.D., Razina T.G., Zueva E.P. et al. Plants in complex therapy of tumors. Мoscow: RAMS Publishing House, 2008. 432 p. (In Russ.).Гольдберг Е.Д., Разина Т.Г., Зуева Е.П. и др. Растения в комплексной терапии опухолей. М.: Издательство РАМН, 2008. 432 с.Xia T., Wang Y.N., Zhou C.X. et al. Ginsenoside Rh2 and Rg3 inhibit cell proliferation and induce apoptosis by increasing mitochondrial reactive oxygen species in human leukemia Jurkat cells. Mol Med Rep 2017;15(6):3591–8. DOI: 10.3892/mmr.2017.6459.Gum S.I., Rahman M.K., Won J.S. et al. A Distinctive Pattern of Beauveria bassiana – biotransformed ginsenoside products triggers mitochondria/FasLmediated apoptosis in colon cancer cells. Phytother Res 2016;30(1):136–43. DOI: 10.1002/ptr.5513.Wang J.-H., Nao J.-F., Zhang M., He P. 20(S)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumour Biol 2014;35(12):11985–94. DOI: 10.1007/s13277-014-2497-5.Wang J., Ren Y.L. Experimental study of the effects on proliferation and apoptosis of A549 cell line adrenocarcinoma of the lung with compatibility of Radix ex Rhizoma ginseng and Fatces Trogopterori. Zhongguo Zhong Yao Za Zhi 2006;31(7):585–8.Tian L., Shen D., Li X. еt al. Ginsenoside Rg3 inhibits epithelialmesenchymal transition (EMT) and invasion of lung cancer by downregulating FUT4. Oncotarget 2016;7(2):1619–32. DOI: 10.18632/oncotarget.6451.Liu T., Zhao L., Hou H. еt al. Ginsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxiainducible factor 1 alpha and nuclear factor-kappa B signals. Tumour Biol 2017;39(5):1010428317692225. DOI: 10.1177/1010428317692225.Lu S., Luo Y., Zhou P. et al. Ginsenoside compound K protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury via inhibition of nuclear factor-κB, p38, and JNK MAPK pathways. J Ginseng Res 2019;43(1):95–104. DOI: 10.1016/j.jgr.2017.09.004.Wang N., Wan J.B., Chan S.W. et al. Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion. Chin Med 2011;(6):37. DOI: 10.1186/1749-8546-6-37.Hu J., Gu Y., Fan W. Rg1 protects rat bone marrow stem cells against hydrogen peroxide-induced cell apoptosis through the PI3K/Akt pathway. Mol Med Rep 2016;14(1):406–12. DOI: 10.3892/mmr.2016.5238.Zhou P., Xie W., Sun Y. et al. Ginsenoside Rb1 and mitochondria: a short review of the literature. Mol Cell Probes 2019;43:1–5. DOI: 10.1016/j.mcp.2018.12.001.Yue P.Y., Wong D.Y., Wu P.K. et al. The angiosuppressive effects of 20 (R)- ginsenoside Rg3. Biochem Pharmacol 2006;72(4):437–45. DOI: 10.1016/j.bcp.2006.04.034.Liu X., Zhang Z., Liu J. et al. Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice. Int Immunopharmacol 2019;72:98–111. DOI: 10.1016/j.intimp.2019.04.003.Leung K.W., Cheung L.W., Pon Y.L. еt al. Ginsenoside Rbl inhibits tube-like structure formulation on endothelian cells by regulating pigment epitheliumderived factor through the oestrogen β-receptor. Br J Pharmacol 2007;152(2):207–15. DOI: 10.1038/sj.bjp.0707359.Zhang E., Shi H., Yang L. et al. Ginsenoside Rd regulates the Akt/ mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth. Oncol Rep 2017;38(1):359–67. DOI: 10.3892/or.2017.5652.Meng L., Ji R., Dong X. et al. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways. Int J Oncol 2019;54(6):2069–79. DOI: 10.3892/ijo.2019.4787.Dai D., Zhang C.F., Williams S. еt al. Ginseng on cancer: potential role in modulating inflammation – mediated angiogenesis. Am J Chin Med 2017;45(1):13–22. DOI: 10.1142/S0192415X17500021.Vinh L.B., Park J.U., Duy L.X. et al. Ginsenosides from Korean red ginseng modulate T cell function via the regulation of NF-AT-mediated IL-2 production. Food Sci Biotechnol 2018;28(1):237–42. DOI: 10.1007/s10068-018-0428-8.Kim D.H., Moon Y.S., Lee T.H. еt al. The inhibitory effect of ginseng saponines on the stress-induced plasma interleukin-6 level in mice. Neurosci Lett 2003;353(1):13–6. DOI: 10.1016/j.neulet.2003.08.070.Lee J.Y., Shin J.W., Chunk K.S. еt al. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxodiol-type ginsenosides in mouse skin. Carcinogenesis 2005;26(2):359–67. DOI: 10.1093/carcin/bgh313.Zhou X., Shi H., Jiang G. et al. Antitumor activities of ginseng polysaccharide in C57BL/6 mice with Lewis lung carcinoma. Tumour Biol 2014;35(12):12561–6. DOI: 10.1007/s13277-014-2576-7.Meng Q., Pan J., Liu Y. et al. Antitumour effects of polysaccharide extracted from Acanthopanax senticosus and cell-mediated immunity. Exp Ther Med 2018;15(2):1694–701. DOI: 10.3892/etm.2017.5568.Bocharova O.A., Serebryakova R.V., Bodrova N.B. Preventive effect of Rhodiola rosea in spontaneous liver carcinogenesis in a mice model of hightumor strain. Vestnik Rossiyskoy akademii meditsinskikh nauk = Annals of the Russian Academy of Medical Sciences 1994;(5):41–3. (In Russ.).Бочарова О.А., Серебрякова Р.В., Бодрова Н.Б. Профилактический эффект Rhodiola rosea на спонтанное опухолеобразование в печени на модели высокораковой линии мышей. Вестник Российской академии медицинских наук 1994;(5):41–3.Bocharova O.A., Serebryakova R.V., Golubeva V.A. et al. Mechanical integration changes of transitional epithelial cells and the immune status of patients with bladder tumors. Urologiya i nefrologiya = Urology and Nephrology 1994;(3):76–80. (In Russ.).Бочарова О.А., Серебрякова Р.В., Голубева В.А. и др. Изменение механической интеграции клеток переходного эпителия и иммунного статуса больных с опухолями мочевого пузыря. Урология и нефрология 1994;(3):76–80.Bocharova O.A., Matveev B.P., Baryshnikov A.Yu. et al. The effect of Rhodiola rosea extract on the recurrence rate of superficial bladder cancer. Urologiya i nefrologiya = Urology and Nephrology 1995;(2):46–7. (In Russ.).Бочарова О.А., Матвеев Б.П., Барышников А.Ю. и др. Влияние экстракта Rhodiola rosea на частоту рецидивов поверхностного рака мочевого пузыря у людей. Урология и нефрология 1995;(2):46–7.Choi J.G., Jin Y.H., Lee H. et al. Protective effect of Panax notoginseng root water extract against influenza a virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity. Front Immunol 2017;8:1542. DOI: 10.3389/fimmu.2017.01542.He L.X., Ren J.W., Liu R. et al. Ginseng (Panax ginseng Meyer) oligopeptides regulate innate and adaptive immune responses in mice via increased macrophage phagocytosis capacity, NK cell activity and Th cells secretion. Food Funct 2017;8(10):3523–32. DOI: 10.1039/c7fo00957g.Chen L.X., Qi Y.L., Qi Z. et al. A Comparative study on the effects of different parts of Panax ginseng on the immune activity of cyclophosphamide-induced immunosuppressed mice. Molecules 2019;24(6):1096. DOI: 10.3390/molecules24061096.Karra A.G., Konstantinou M., Tzortziou M. et al. Potential dissociative glucocorticoid receptor activity for protopanaxadiol and protopanaxatriol. Int J Mol Sci 2018;20(1):94. DOI: 10.3390/ijms20010094.Kim H.S., Lee E.H., Ко S.R. еt al. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharmacol Res 2004;27(4): 429–35. DOI: 10.1007/bf02980085.Seo B.Y., Choi M.J., Kim J.S., Park E. Comparative analysis of ginsenoside profiles: antioxidant, antiproliferative, and antigenotoxic activities of ginseng extracts of fine and main roots. Prev Nutr Food Sci 2019;24(2):128–35. DOI: 10.3746/pnf.2019.24.2.128.Kim H.G., Jang S.S., Lee J.S. et al. Panax ginseng Meyer prevents radiationinduced liver injury via modulation of oxidative stress and apoptosis. J Ginseng Res 2017;41(2):159–68. OI: 10.1016/j.jgr.2016.02.006.Kurennaya O.N., Karpova R.V., Bocharova O.А. et al. Multiphytoadaptogen antimutagenesis in yeast cells of saccharomyces. Genetika = Russian Journal of Genetiсs 2013;49(12):1364–9. (In Russ.).Куренная О.Н., Карпова Р.В., Бочарова О.А. и др. Антимутагенез мультифитоадаптогена в клетках дрожжей-сахаромицетов. Генетика 2013;49(12):1364–9.Xu L., Wang X.Y., Liu S.L., Zhang J.-T. Two forms of long-term potentiation induced by different compounds. J Asian Nat Prod Res 2007;9(3–5):217–22. DOI: 10.1080/10286020500532066.Zhang Q.H., Wu C.F., Duan L. Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse marrow bone cells and peripheral lymphocytes cells. Food Chem Toxicol 2008;46(1):293–302. DOI: 10.1016/j.fct.2007.08.025.Jin J., Shahi S., Kang H.K. et al. Metabolites of ginsenosides as novel BCRP inhibitors. Biochem Biophys Res Commun 2006;345(4):1308–14. DOI: 10.1016/j.bbrc.2006.04.152.Kim C., Lee J.H., Baek S.H. еt al. Korean Red Ginseng Extract Enhances the anticancer effects of sorafenib through abrogation of CREB and c-Jun activation in renal cell carcinoma. Phytother Res 2017;31(7):1078–89. DOI: 10.1002/ptr.5829.Aung H.H., Mehendale S.R., Wang C.Z. et al. Cisplatin’s tumoricidal effect on human breast carcinoma MCF7 cells was not attenuated by American ginseng. Cancer Chemoter Pharmacol 2007;59(3):369–74. DOI: 10.1007/s00280-006-0278-6.Wang C.J., Xie J.T., Zhang B. et al. Chemopreventive effects of Panax notoginseng and its major constituens on SW480 human colorectal cancer cells. Int J Oncol 2007;31(5):1149–56. DOI: 10.3892/ijo.31.5.1149.Li L., Lu Q., Shen Y., Hu X. Schisandrin В enhances doxorubicininduced apoptosis of cancer cells but not normal cells. Biochem Pharmacol 2006;71(5):584–95. DOI: 10.1016/j.bcp.2005.11.026.Kormosh N., Laktionov K., Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res 2006;20(5):424–5. DOI: 10.1002/ptr.1889.Ma J., Gao G., Lu H. et al. Reversal effect of ginsenoside Rh2 on oxaliplatinresistant colon cancer cells and its mechanism. Exp Ther Med 2019;18(1): 630–6. DOI: 10.3892/etm.2019.7604.Kim H.S., Kim M.K., Lee M. еt al. Effect of Red Ginseng on genotoxicity and health-related quality of life after adjuvant chemotherapy in patients with epithelial ovarian cancer: a randomized, double blind, placebo-controlled trial. Nutrients 2017;9(7):772. DOI: 10.3390/nu9070772.Liu J., He J., Huang L. еt al. Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth. Neural Regen Res 2014;9(9):943–50. DOI: 10.4103/1673-5374.133137.Kim K.H., Lee D., Lee H.L. et al. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res 2018;42(3):239–47. DOI: 10.1016/j.jgr.2017.03.011.Wang G.L., He Z.M., Zhu H.Y. et al. Involvement of serotonergic, noradrenergic and dopaminergic systems in the antidepressant-like effect of ginsenoside Rb1, a major active ingredient of Panax ginseng C.A. Meyer. J Ethnopharmacol 2017;204:118–24. DOI: 10.1016/j.jep.2017.04.009.Wang G.L., Wang Y.P., Zheng J.Y., Zhang L.X. Monoaminergic and aminoacidergic receptors are involved in the antidepressant-like effect of ginsenoside Rb1 in mouse hippocampus (CA3) and prefrontal cortex. Brain Res 2018;1699:44–53. DOI: 10.1016/j.brainres.2018.05.035.Bocharova O.A., Figurin L.M., Serebryakova R.V. et al. Rhodiolae Rosea in correction of urothelial cells adhesion and immune status in patients with superficial cancer of the bladder. Immunologiya = Immunology 1997;18(1):67–70. (In Russ.).Бочарова О.А., Фигурин Л.М., Серебрякова Р.В. и др. Коррекция препаратом Rhodiola rosea адгезии клеток уротелия и иммунного статуса у больных поверхностным раком мочевого пузыря. Иммунология 1997;18(1):51–5.Shanmugam M.K., Lee J.H., Chai E.Z. et al. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. Semin Cancer Biol 2016;(40, 41):35–47. DOI: 10.1016/j.semcancer.2016.03.005.Yan Z., Yang R., Jiang Y. et al. Induction of apoptosis in human promyelocytic leukemia HL60 cells by panaxynol and panaxydol. Molecules 2011;16(7):5561–73. DOI: 10.3390/molecules16075561.Qi L.W., Wang C.Z., Yuan C.S. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry 2011;72(8):689–99. DOI: 10.1016/j.phytochem.2011.02.012.Belitskij G.A., Kirsanov K.I., Lesovaya E.A., Yakubovskaya M.G. The mechanisms of flavonoids anticancer action. Uspekhi molekulyarnoj onkologii = Advances in Molecular Oncology 2014;(1):56–68. (In Russ.).Белицкий Г.А., Кирсанов К.И., Лесовая Е.А., Якубовская М.Г. Механизмы антиканцерогенного действия флавоноидов. Успехи молекулярной онкологии 2014;(1):56–68.Nekkanti S., Tokala R., Shankaraiah N. Targeting DNA minor groove by hybrid molecules as anticancer agents. Curr Med Chem 2017;24(26):2887–907. DOI: 10.2174/0929867324666170523102730.